This program is worth 1.0 CME credits.
Chronic pain syndrome affects nearly 30% of the population and causes disability for nearly 8%. This can include headache, back, neck, extremity, and abdominal pain. Multidisciplinary approaches can address multiple factors that contribute to pain. This treatment requires multiple specialists (including medical and mental health professionals and physical/occupational therapists) to provide care in a coordinated process. Understanding when to utilize this approach as well as how to locate or create such programs is critical to improve the outcomes for our chronic pain patients.
This is the third in an ongoing series of webinars addressing opioid use in neurology. AAN is collaborating with Providers’ Clinical Support System for Opioid Therapies (PCSS-O), a national training and mentoring project developed in response to the prescription opioid overdose epidemic, and the Substance Abuse and Mental Health Services Administration.
Teaching Style: Didactic, Audience Participation
Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider
As a result of this program the learner will:
o Define chronic pain syndrome o Assess when chronic opioids may contribute to chronic pain versus benefit o Review the prevalence, chronicity, and impact of chronic pain syndrome o Define biopsychosocial model of pain treatment versus medicopharmacologic approach o Describe the role of the neurologist in a biopsychosocial model of pain treatment o Recognize the benefits of chronic pain rehabilitation
- Patient Care
- Practice-Based Learning and Improvement
- Systems-Based Practice
Date of Release
Dr. Brock reported that he received personal compensation from Wicker Smith Law Firm for medical legal expert reviews, and from PDA for disability consulting. This material has been reviewed by the lead Clinical Expert on the PCSS-O grant, co-faculty, and AAN staff. There is no commercial support for this series. Funding for this initiative was made possible (in part) by Providers’ Clinical Support System for Opioid Therapies (grant no. 5H79TI025595) from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
The American Academy of Neurology Institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The American Academy of Neurology Institute designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Webinars will be recorded and archived to www.pcss-o.org within two weeks of the live training.